Chemistry:Spirobrorphine
From HandWiki
Spirobrorphine is a synthetic opioid chemical compound which has been sold as a designer drug, first reported in the USA in February 2026.[1] It was added to the controlled drug schedules in Canada in June 2026.[2] Its pharmacology has not yet been studied but it is believed to be a potent opioid narcotic in a similar manner to related compounds such as spirochlorphine and R6372.
See also
- N-Propionitrile brorphine
- List of orphine opioids
References
- ↑ "Emerging Global Synthetic Opioid Threats: Benzimidazol-2-ones – The Orphines. Colombo Plan Health Alert, February 2026". https://www.cfsre.org/images/content/reports/public_alerts/Colombo_Plan_Orphine_Alert_Feb_2026_v2.pdf.
- ↑ "Order Amending Schedule V to the Controlled Drugs and Substances Act (R 29676, Spirobrorphine and Spirochlorphine): SOR/2026-71. Canada Gazette, Part II, Volume 160, Number 9. 17 April 2026.". Government of Canada, Public Works and Government Services Canada, Integrated Services Branch, Canada Gazette. https://gazette.gc.ca/rp-pr/p2/2026/2026-05-06/html/sor-dors71-eng.html.
 |  |
